For example, aptamer F5R1 was co-incubated with exosomes derived from the human embryonic kidney (HEK) 293T cells at 37 °C for some time [79], and an aptamer was able to efficiently enter exosomes and reduce a-synuclein aggregation, exerting a therapeutic effect on PD. This evidence concerns the gene SNCA and Parkinson disease.